Home › Funds › ANTIPODES PARTNERS Ltd › ORCL

ANTIPODES PARTNERS Ltd position in ORCL

ORACLE CORP · Technology

ANTIPODES PARTNERS Ltd reported holding 231,707 shares of ORCL (ORACLE CORP) in its Q3 2026 13F filing — a position valued at US$31.8M, representing 0.59% of its reported portfolio and ranking #49 among its reported holdings. ANTIPODES PARTNERS Ltd has disclosed ORCL holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)231.71K sh
Reported value held$31.81M
Portfolio Weight0.59%
First reportedQ3 2023
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ANTIPODES PARTNERS Ltd's ORCL position evolved

ANTIPODES PARTNERS Ltd first disclosed a stake in ORCL in Q3 2023 at 1,702,276 shares (US$180.7M). The position peaked in Q1 2024 at 1,639,887 shares, worth US$206.0M. Across 10 filings, ANTIPODES PARTNERS Ltd increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 231,707 shares valued at US$31.8M. Notable position changes include a 27% trim in Q3 2024 (shares fell 2% over the following quarter), a 43% trim in Q4 2024 (shares fell 17% over the following quarter), a 46% trim in Q1 2025 (shares rose 57% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.70M $180.70M New
Q4 2023 1.66M $175.35M Reduce
Q1 2024 1.64M $205.99M Reduce
Q2 2024 1.25M $176.79M Reduce
Q3 2024 914.15K $155.78M Reduce
Q4 2024 517.99K $86.33M Reduce
Q1 2025 282.07K $39.44M Reduce
Q4 2025 239.69K $46.72M New
Q1 2026 212.12K $31.20M Reduce
Q3 2026 231.71K $31.81M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORCL and 13F data

ORCL (ORACLE CORP) is a Technology company. 24 other funds we track also report a position in ORCL — the largest reported positions include Vanguard Group (US$34.07B), BlackRock Inc (US$21.30B), VANGUARD CAPITAL MANAGEMENT LLC (US$15.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORCL

All ORCL fund holders →

FAQ

How long has ANTIPODES PARTNERS Ltd held ORCL?

ANTIPODES PARTNERS Ltd has disclosed ORCL holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is ANTIPODES PARTNERS Ltd's current position in ORCL?

As of Q3 2026, ANTIPODES PARTNERS Ltd holds 231.71K shares of ORCL (ORACLE CORP), valued at $31.81M, representing 0.59% of its reported portfolio and ranking #49.

Has ANTIPODES PARTNERS Ltd been buying or selling ORCL?

In the latest 13F filing (Q3 2026), ANTIPODES PARTNERS Ltd newly opened its position in ORCL. The position peaked in Q1 2024 at 1.64M shares.

Which other funds hold ORCL?

Other major institutional holders of ORCL include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.